Mirae Asset Global Investments Co., Ltd. Coherus Bio Sciences, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

$22.5 Billion
Q3 2024

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 4,167 shares of CHRS stock, worth $3,416. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,167

Previous 3,425 21.66%

Holding current value

$3,416

Previous $5,000 20.0%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$0.99 - $1.8 $734 - $1,335	742 Added 21.66%	4,167 $4,000
Q2 2024 Jul 30, 2024	SELL	$1.58 - $2.51 $65,922 - $104,724	-41,723 Reduced 92.41%	3,425 $5,000
Q1 2024 May 01, 2024	BUY	$2.02 - $3.14 $91,198 - $141,764	45,148 New	45,148 $107,000
Q3 2023 Oct 26, 2023	BUY	$3.74 - $5.45 $105,737 - $154,082	28,272 Added 64.3%	72,241 $270,000
Q2 2023 Aug 10, 2023	SELL	$3.79 - $8.3 $56,721 - $124,217	-14,966 Reduced 25.39%	43,969 $187,000
Q1 2023 May 04, 2023	BUY	$5.89 - $10.52 $89,086 - $159,115	15,125 Added 34.52%	58,935 $403,000
Q4 2022 Feb 09, 2023	BUY	$5.69 - $10.07 $159 - $281	28 Added 0.06%	43,810 $346,000
Q3 2022 Nov 10, 2022	BUY	$7.17 - $13.87 $168,710 - $326,361	23,530 Added 116.19%	43,782 $421,000
Q2 2022 Jul 26, 2022	SELL	$5.86 - $13.23 $481,674 - $1.09 Million	-82,197 Reduced 80.23%	20,252 $146,000
Q2 2021 Aug 11, 2021	SELL	$12.95 - $15.41 $183,799 - $218,714	-14,193 Reduced 12.17%	102,449 $1.42 Million
Q1 2021 May 13, 2021	SELL	$14.42 - $21.39 $74,955 - $111,185	-5,198 Reduced 4.27%	116,642 $1.7 Million
Q4 2020 Feb 10, 2021	SELL	$16.56 - $18.94 $3,278 - $3,750	-198 Reduced 0.16%	121,840 $2.12 Million
Q3 2020 Nov 12, 2020	BUY	$17.41 - $19.89 $712,486 - $813,978	40,924 Added 50.45%	122,038 $2.28 Million
Q2 2020 Aug 11, 2020	SELL	$14.43 - $19.16 $541,933 - $719,572	-37,556 Reduced 31.65%	81,114 $1.45 Million
Q1 2020 May 12, 2020	SELL	$11.67 - $22.53 $585,612 - $1.13 Million	-50,181 Reduced 29.72%	118,670 $1.93 Million
Q4 2019 Feb 12, 2020	SELL	$16.33 - $21.37 $905,678 - $1.19 Million	-55,461 Reduced 24.72%	168,851 $3.04 Million
Q3 2019 Nov 12, 2019	SELL	$16.3 - $23.37 $1.26 Million - $1.81 Million	-77,363 Reduced 25.64%	224,312 $4.54 Million
Q2 2019 Aug 13, 2019	BUY	$13.1 - $22.1 $2,541 - $4,287	194 Added 0.06%	301,675 $6.67 Million
Q1 2019 May 13, 2019	BUY	$8.38 - $15.5 $90,453 - $167,307	10,794 Added 3.71%	301,481 $4.11 Million
Q4 2018 Feb 11, 2019	SELL	$8.65 - $16.28 $735,120 - $1.38 Million	-84,985 Reduced 22.62%	290,687 $2.63 Million
Q3 2018 Nov 13, 2018	BUY	$14.45 - $20.25 $672,329 - $942,192	46,528 Added 14.14%	375,672 $6.2 Million
Q2 2018 Aug 14, 2018	BUY	$10.25 - $17.45 $3.37 Million - $5.74 Million	329,144 New	329,144 $4.61 Million

Others Institutions Holding CHRS

# of Institutions

140

Shares Held

76.8M

Call Options Held

79.1K

Put Options Held

100K

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $63.7M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Coherus Bio Sciences, Inc. Transaction History